Dietary DHA/EPA Ratio Changes Fatty Acid Composition and Attenuates Diet-Induced Accumulation of Lipid in the Liver of ApoE−/− Mice
Table 5
Fatty acid composition (%) of the serum of mice during the experimental period.
Serum fatty acid
ND ()
HFD ()
DHA/EPA = 2 : 1 ()
DHA/EPA = 1 : 1 ()
DHA/EPA = 1 : 2 ()
C16:0
22.881 ± 0.863
23.293 ± 0.271
22.759 ± 0.762
22.068 ± 0.763
20.838 ± 1.006
C16:1
1.069 ± 0.117
1.473 ± 0.145a
0.773 ± 0.287b
0.65 ± 0.168b
0.666 ± 0.174b
C18:0
8.151 ± 0.345
11.729 ± 0.440a
9.163 ± 0.510b
9.071 ± 0.336b
8.871 ± 0.576b
C18:1
16.136 ± 0.603
26.315 ± 0.857a
17.374 ± 1.279b
16.886 ± 1.21b
16.174 ± 1.967b
C18:2
30.819 ± 1.416
20.912 ± 0.605a
30.538 ± 1.028b
30.515 ± 1.039b
28.062 ± 1.046a,b
C18:3
0.00 ± 0.00
0.00 ± 0.00
0.04 ± 0.08
0.00 ± 0.00
0.00 ± 0.00
C19:0
0.836 ± 0.040
0.538 ± 0.137
0.500 ± 0.168
0.266 ± 0.1646a
0.260 ± 0.162a
C20:0
0.112 ± 0.112
0.082 ± 0.0.082
0.133 ± 0.133
0.098 ± 0.098
0.00 ± 0.00
C20:1
0.106 ± 0.106
0.228 ± 0.140
0.748 ± 0.329
0.416 ± 0.289
0.424 ± 0.309
C20:4
4.265 ± 0.272
7.177 ± 0.458a
3.67 ± 0.132b
3.946 ± 0.126b
4.242 ± 0.184b
C22:0
2.01 ± 0.059
0.660 ± 0.093
4.018 ± 1.264a,b
4.383 ± 0.518a,b
5.472 ± 0.775a,b
C20:5
0.752 ± 0.313
0.00 ± 0.00a
0.275 ± 0.166
0.102 ± 0.102a
0.130 ± 0.130a
C22:6
7.028 ± 0.305
3.555 ± 0.221a
8.389 ± 0.371a,b
8.347 ± 0.265a,b
7.358 ± 0.429b,c,d
∑SFAs
33.987 ± 1.153
36.305 ± 0.321
36.575 ± 0.697
35.885 ± 0.986
35.439 ± 0.969
∑MUFAs
17.314 ± 0.598
28.018 ± 0.805a
18.895 ± 1.131b
17.952 ± 1.090b
17.266 ± 1.845b
∑PUFAs
42.866 ± 1.969
31.648 ± 0.510a
42.878 ± 1.189b
42.908 ± 0.721b
39.794 ± 1.124b
∑n-6
35.086 ± 1.659
28.092 ± 0.339a
34.213 ± 1.021b
34.460 ± 0.927b
32.306 ± 1.134b
∑n-3
7.780 ± 0.393
3.556 ± 0.222a
8.665 ± 0.493b
8.448 ± 0.253b
7.488 ± 0.388b,c
n-6/n-3
4.522 ± 0.162
8.016 ± 0.469a
3.983 ± 0.241b
4.105 ± 0.224b
4.372 ± 0.320b
Data are given as the mean ± SEM. a versus the ND group; b versus the HFD group; c versus the DHA/EPA = 2 : 1 group; d versus the DHA/EPA = 1 : 1 group.